Cresset Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Cresset Asset Management's MDT Position: Q2 2026 in Review
Cresset Asset Management increased its Medtronic (MDT) stake by 1.1% in Q2 2026, buying an estimated $183K and bringing the position to 201,891 shares worth $15.9M. The position accounts for 0.06% of the portfolio, ranked #197.
Cresset Asset Management first reported a position in MDT in Q4 2018 and has held it in 31 quarters since. The position peaked at $30.4M in Q3 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Cresset Asset Management held 201,891 shares of Medtronic worth $15.9M as of Q2 2026.
- Cresset Asset Management bought 2,265 Medtronic shares in Q2 2026, an estimated $183K.
- Medtronic made up 0.06% of Cresset Asset Management's portfolio in Q2 2026, its #197 holding.
- Cresset Asset Management first reported a position in Medtronic in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's Medtronic position peaked at $30.4M in Q3 2024.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.